Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1953 1
1960 1
1961 1
1962 2
1964 2
1965 1
1966 2
1967 3
1968 2
1969 1
1970 5
1971 5
1972 7
1973 4
1974 3
1975 1
1976 3
1977 5
1978 9
1979 2
1980 6
1981 7
1982 11
1983 13
1984 12
1985 13
1986 21
1987 17
1988 21
1989 31
1990 24
1991 20
1992 19
1993 22
1994 35
1995 33
1996 32
1997 32
1998 32
1999 27
2000 37
2001 43
2002 52
2003 48
2004 47
2005 56
2006 53
2007 38
2008 45
2009 42
2010 47
2011 54
2012 39
2013 47
2014 46
2015 54
2016 64
2017 49
2018 59
2019 69
2020 91
2021 97
2022 67
Text availability
Article attribute
Article type
Publication date

Search Results

1,596 results
Results by year
Filters applied: . Clear all
Page 1
Psoriasis and Antimicrobial Peptides.
Takahashi T, Yamasaki K. Takahashi T, et al. Among authors: yamasaki k. Int J Mol Sci. 2020 Sep 16;21(18):6791. doi: 10.3390/ijms21186791. Int J Mol Sci. 2020. PMID: 32947991 Free PMC article. Review.
Effects of Inhaled Corticosteroid/Long-Acting β2-Agonist Combination on the Airway Microbiome of Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Clinical Trial (DISARM).
Leitao Filho FS, Takiguchi H, Akata K, Ra SW, Moon JY, Kim HK, Cho Y, Yamasaki K, Milne S, Yang J, Yang CWT, Li X, Nislow C, van Eeden SF, Shaipanich T, Lam S, Leung JM, Sin DD. Leitao Filho FS, et al. Among authors: yamasaki k. Am J Respir Crit Care Med. 2021 Nov 15;204(10):1143-1152. doi: 10.1164/rccm.202102-0289OC. Am J Respir Crit Care Med. 2021. PMID: 34464242 Clinical Trial.
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.
Fujimoto K, Arita H, Satomi K, Yamasaki K, Matsushita Y, Nakamura T, Miyakita Y, Umehara T, Kobayashi K, Tamura K, Tanaka S, Higuchi F, Okita Y, Kanemura Y, Fukai J, Sakamoto D, Uda T, Machida R, Kuchiba A, Maehara T, Nagane M, Nishikawa R, Suzuki H, Shibuya M, Komori T, Narita Y, Ichimura K. Fujimoto K, et al. Among authors: yamasaki k. Acta Neuropathol. 2021 Aug;142(2):323-338. doi: 10.1007/s00401-021-02337-9. Epub 2021 Jun 20. Acta Neuropathol. 2021. PMID: 34148105
Serum Albumin, Lipid and Drug Binding.
Nishi K, Yamasaki K, Otagiri M. Nishi K, et al. Among authors: yamasaki k. Subcell Biochem. 2020;94:383-397. doi: 10.1007/978-3-030-41769-7_15. Subcell Biochem. 2020. PMID: 32189308 Review.
Ustekinumab treatment for hidradenitis suppurativa.
Takeda K, Kikuchi K, Kanazawa Y, Yamasaki K, Aiba S. Takeda K, et al. Among authors: yamasaki k. J Dermatol. 2019 Dec;46(12):1215-1218. doi: 10.1111/1346-8138.15122. Epub 2019 Oct 22. J Dermatol. 2019. PMID: 31638283
Radiation-induced osteosarcoma in a patient with DICER1 syndrome.
Tanimura K, Nakano Y, Sato-Otsubo A, Yamasaki K, Fukushima H, Tanaka M, Yoshioka T, Okita H, Kunihiro N, Sakamoto H, Inoue T, Fujisaki H, Hara J. Tanimura K, et al. Among authors: yamasaki k. Pediatr Blood Cancer. 2022 May 20:e29782. doi: 10.1002/pbc.29782. Online ahead of print. Pediatr Blood Cancer. 2022. PMID: 35593689 No abstract available.
Thiotepa-melphalan myeloablative therapy for high-risk neuroblastoma.
Yamazaki F, Yamasaki K, Kiyotani C, Hashii Y, Shioda Y, Hara J, Matsumoto K. Yamazaki F, et al. Among authors: yamasaki k. Pediatr Blood Cancer. 2021 Jun;68(6):e28896. doi: 10.1002/pbc.28896. Epub 2021 Mar 31. Pediatr Blood Cancer. 2021. PMID: 33788375
1,596 results